IPOs, Initial Public Offerings: pre & post IPO

Sept 16wk archive

Print this entry

This is probably why BIND, FPRX underperformed the week of Sept 16 and FATE was postponed.  XLRN held up, however.  “Prosensa Sinks as Muscular Dystrophy Drug Fails in Trial”  here

BIND   BNFT  FATE   FEYE  FPRX   FUEL  MYCC  VLRS   XLRN

IPO Calendar

Manager

Exp

   Price Range

Est$

Exptd

Smry

 

 

shares

 

IPO size

date

 

 

 

 

 

 

 

 

recommendations at price range mid-point

Week of Sept 16, 2013

 

 

 

 

 

 

Ranked by size of IPO

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Low priced Mexican airline

 

 

 

 

 

Volaris Aviation Holding (VLRS)  Priced at $12

Deutsche; Morgan Stanley; UBS Investment

28.9

12

14

$376

Wed

Neutral P/E is too high  C+, 7

 

 

 

 

 

 

 

 

Golf & country clubs

 

 

 

 

 

 

ClubCorp Holdings (MYCC)  Priced at $14

Goldman, Sachs/ Jefferies/ Citigroup/ BofA Merrill Lynch/ Deutsche Bank Securities

18

16

18

$306

Fri

Neutral to negative, C+, 7

 

 

 

 

 

 

 

 

Cyber security platform

 

 

 

 

 

 

FireEye (FEYE)  Priced at $20

Morgan Stanley, Goldman, Sachs/ J.P. Morgan/ Barclays

14

12

14

$182

Fri

Buy, C, 7

 

 

 

 

 

 

 

 

AI & bigdata

 

 

 

 

 

 

 

Rocket Fuel (FUEL)  Priced at $29

Credit Suisse/ Citigroup

4

24

27

$102

Fri

Buy, C, 7

 

 

 

 

 

 

 

 

Cloud-based software for employers & insurance cos

 

Benefitfocus (BNFT)  Priced at $26.50, 4.9 mm shrs

Goldman, Sachs/ Deutsche Bank Securities/ Jefferies

4.5

21.5

24.5

$104

Wed

Neutral to positive, C, 7

 

 

 

 

 

 

 

 

Nanomedicine platform

 

 

 

 

 

 

BIND Therapeutics (BIND)  Priced at $15

Credit Suisse/ Cowen

4.7

14

16

$71

Fri

Buy, C, 7

 

 

 

 

 

 

 

 

Biopharma

 

 

 

 

 

 

 

Acceleron Pharma (XLRN)  Priced at $15, 5.6mm shrs

Citigroup/ Leerink Swann

4.7

13

15

$66

Thurs

Buy, C+, 7

 

 

 

 

 

 

 

 

Biopharma

 

 

 

 

 

 

 

Fate Therapeutics (FATE)  Postponed

Cowen; BMO Capital

4

14

16

$60

Thurs

Buy, C, 6

 

 

 

 

 

 

 

 

Biotech

 

 

 

 

 

 

 

Five Prime Therapeutics (FPRX)  Priced at $13

Jefferies/ BMO Capital Markets/ Wells Fargo Securities

4

12

14

$52

Wed

Buy, C, 7

 

 

 

 

 

 

 

 

Held over from Sept 9th week

 

 

 

 

 

IT valued added services

 

 

 

 

 

 

InterCloud Systems (ICLD)

Aegis Capital

2

9

11

$20

Wed

(*)

(*) already traded on OTCQB

 

 

 

 

 


8 Trackbacks

  • By porridge on November 30, 2016 at 5:02 pm

    … [Trackback]

    […] There you will find 11280 more Infos: ipopremium.com/sept-16wk-archive/ […]

  • By Yarnell Hill Fire on November 29, 2016 at 6:05 am

    … [Trackback]

    […] Informations on that Topic: ipopremium.com/sept-16wk-archive/ […]

  • By hire a lawyer on November 27, 2016 at 2:02 pm

    … [Trackback]

    […] Read More here: ipopremium.com/sept-16wk-archive/ […]

  • By http://www.mckenzieandwillis.co.nz/ on November 25, 2016 at 2:44 pm

    … [Trackback]

    […] Find More Informations here: ipopremium.com/sept-16wk-archive/ […]

  • By buy hcg 5000 iu on November 22, 2016 at 5:15 pm

    … [Trackback]

    […] Find More Informations here: ipopremium.com/sept-16wk-archive/ […]

  • By cul on November 21, 2016 at 9:59 am

    … [Trackback]

    […] Find More Informations here: ipopremium.com/sept-16wk-archive/ […]

  • By kimim ben on November 19, 2016 at 12:06 pm

    … [Trackback]

    […] Informations on that Topic: ipopremium.com/sept-16wk-archive/ […]

  • By computer reparatie Aalten on November 14, 2016 at 9:52 am

    … [Trackback]

    […] There you will find 38217 more Infos: ipopremium.com/sept-16wk-archive/ […]

Leave a Reply

 

Login

Lost your password?